Next Article in Journal
Cardiac Stimulation in the Third Millennium: Where Do We Head from Here?
Previous Article in Journal
Life Threatening Reactive Left Ventricular Hypertrophy Due to Increased Blood Flow after Coronary Artery Bypass Grafting
Open AccessStudy Protocol

Non-Invasive Assessment of Pulmonary Vasculopathy

1
Cardiology Department University Hospital 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain
2
Centro Nacional de Investigaciones Cardiovasculares Carlos III, 28029 Madrid, Spain
3
Centro de Investigación Biomédica En Red Cardiovascular (CIBERCV), 28029 Madrid, Spain
4
Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain
5
Philips Healthcare, 28050 Madrid, Spain
6
IIS-Fundación Jiménez Díaz Hospital, 28040 Madrid, Spain
*
Author to whom correspondence should be addressed.
Received: 2 December 2020 / Revised: 28 December 2020 / Accepted: 31 December 2020 / Published: 5 January 2021
Right heart catheterization remains necessary for the diagnosis of pulmonary hypertension and, therefore, for the prognostic evaluation of patients with chronic heart failure. The non-invaSive Assessment of Pulmonary vasculoPathy in Heart failure (SAPPHIRE) study was designed to assess the feasibility and prognostic relevance of a non-invasive evaluation of the pulmonary artery vasculature in patients with heart failure and pulmonary hypertension. Patients will undergo a right heart catheterization, cardiac resonance imaging, and a pulmonary function test in order to identify structural and functional parameters allowing the identification of combined pre- and postcapillary pulmonary hypertension, and correlate these findings with the hemodynamic data. View Full-Text
Keywords: heart failure; pulmonary hypertension; cardiovascular magnetic resonance; right heart catheterization heart failure; pulmonary hypertension; cardiovascular magnetic resonance; right heart catheterization
Show Figures

Figure 1

MDPI and ACS Style

Ponz, I.; Nuche, J.; Sanchez Sanchez, V.; Sanchez-Gonzalez, J.; Blazquez-Bermejo, Z.; Caravaca Perez, P.; Garcia-Cosio Carmena, M.D.; de Juan Baguda, J.S.; Rodríguez Chaverri, A.; Sarnago Cebada, F.; Arribas Ynsaurriaga, F.; Ibañez, B.; Delgado Jiménez, J.F. Non-Invasive Assessment of Pulmonary Vasculopathy. Hearts 2021, 2, 5-14. https://0-doi-org.brum.beds.ac.uk/10.3390/hearts2010002

AMA Style

Ponz I, Nuche J, Sanchez Sanchez V, Sanchez-Gonzalez J, Blazquez-Bermejo Z, Caravaca Perez P, Garcia-Cosio Carmena MD, de Juan Baguda JS, Rodríguez Chaverri A, Sarnago Cebada F, Arribas Ynsaurriaga F, Ibañez B, Delgado Jiménez JF. Non-Invasive Assessment of Pulmonary Vasculopathy. Hearts. 2021; 2(1):5-14. https://0-doi-org.brum.beds.ac.uk/10.3390/hearts2010002

Chicago/Turabian Style

Ponz, Ines; Nuche, Jorge; Sanchez Sanchez, Violeta; Sanchez-Gonzalez, Javier; Blazquez-Bermejo, Zorba; Caravaca Perez, Pedro; Garcia-Cosio Carmena, Maria D.; de Juan Baguda, Javier S.; Rodríguez Chaverri, Adriana; Sarnago Cebada, Fernando; Arribas Ynsaurriaga, Fernando; Ibañez, Borja; Delgado Jiménez, Juan F. 2021. "Non-Invasive Assessment of Pulmonary Vasculopathy" Hearts 2, no. 1: 5-14. https://0-doi-org.brum.beds.ac.uk/10.3390/hearts2010002

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop